Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
VERASEAL (Grifols Australia Pty Ltd)
Product name
VERASEAL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
251 (255 working days)
Active ingredients
human fibrinogen; human thrombin
Registration type
NCE/NBE
Indication
VERASEAL (solutions for sealant) is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.